In a 45-year-old woman with a one‑month history of painless jaundice, weight loss, altered mental status, ascites, distended abdominal veins, anemia with low haptoglobin, normal reticulocyte count, low lactate dehydrogenase, and a cholestatic pattern (markedly elevated alkaline phosphatase and gamma‑glutamyltransferase, elevated direct bilirubin, modest transaminase elevations), what is the most likely diagnosis?

Most Probable Diagnosis: Pancreatic Head Adenocarcinoma

The most probable diagnosis is pancreatic head adenocarcinoma, given the constellation of painless progressive jaundice, weight loss, malaise, markedly elevated cholestatic enzymes (alkaline phosphatase 1,150 U/L, GGT 950 U/L), and signs of advanced disease (ascites, distended abdominal veins suggesting portal hypertension).

Clinical Reasoning

Cholestatic Pattern Confirms Biliary Obstruction

• The laboratory profile demonstrates a classic cholestatic pattern with alkaline phosphatase elevated to 1,150 U/L and GGT to 950 U/L, while transaminases are only modestly elevated (ALT 80 U/L, AST 120 U/L), yielding an R-value of approximately 0.15—well below the cholestatic threshold of ≤2. 1

• Direct bilirubin of 7.3 mg/dL (out of total 12 mg/dL) confirms conjugated hyperbilirubinemia, the hallmark of biliary obstruction rather than hemolysis or hepatocellular injury. 2

• Painless jaundice with pale stools and dark urine is the classic presentation of malignant biliary obstruction, particularly from pancreatic head carcinoma or distal cholangiocarcinoma. 1, 2

Excluding Alternative Diagnoses

Acute hemolysis is ruled out by the normal reticulocyte count (1.2%), normal haptoglobin (60 mg/dL), and low lactate dehydrogenase (90 U/L)—hemolysis would produce elevated indirect bilirubin, elevated LDH, low haptoglobin, and reticulocytosis. 2

Alcoholic hepatitis is unlikely because:

• The patient drinks alcohol "in moderation" (not the heavy consumption required for alcoholic hepatitis)
• The AST/ALT ratio is 1.5 (alcoholic hepatitis typically shows AST/ALT >2 in 70% of cases)
• The cholestatic pattern (ALP 1,150 U/L) is atypical for alcoholic hepatitis, which predominantly elevates transaminases 3

Autoimmune hepatitis is improbable because:

• Autoimmune hepatitis typically presents with a hepatocellular pattern (elevated transaminases >> alkaline phosphatase)
• The R-value here is 0.15 (cholestatic), whereas autoimmune hepatitis produces R ≥5 (hepatocellular)
• Autoimmune hepatitis rarely causes such marked cholestatic enzyme elevation without normalization on immunosuppression 3

Viral hepatitis is excluded by:

• The cholestatic pattern (viral hepatitis produces hepatocellular injury with ALT/AST >>1,000 U/L)
• The one-month duration of progressive symptoms (acute viral hepatitis evolves over days to weeks with acute illness)
• Absence of risk factors mentioned in the history 3

Malignancy as the Leading Cause

• Pancreatic head adenocarcinoma is the most common cause of painless obstructive jaundice in a middle-aged adult, typically presenting with progressive jaundice and weight loss in about one-third of patients. 2

• The combination of ascites and distended abdominal veins indicates advanced disease with peritoneal carcinomatosis or portal vein involvement, features commonly seen in late-stage pancreatic cancer. 1, 2

• Cholangiocarcinoma presents with painless jaundice in 84–90% of cases, frequently accompanied by weight loss and constitutional symptoms; however, it is less common than pancreatic head carcinoma and typically does not cause ascites unless very advanced. 2

• Altered mental status in this context likely reflects hepatic encephalopathy from severe cholestasis or metabolic derangements secondary to malignancy, rather than a primary neurologic process. 2

• Serum bilirubin of 12 mg/dL with alkaline phosphatase >1,000 U/L strongly suggests malignant obstruction rather than benign causes; in a prospective study of 220 patients with jaundice, mean bilirubin and alkaline phosphatase were significantly higher in malignant disease (p<0.001). 4

Diagnostic Approach

• Abdominal ultrasound is the mandatory first imaging study to assess for biliary dilatation, pancreatic head mass, and liver metastases, with sensitivity of 32–100% for detecting biliary obstruction. 2, 5

• If ultrasound demonstrates biliary dilatation, proceed directly to contrast-enhanced CT or MRCP to characterize the pancreatic mass, assess resectability, and stage the disease. 2, 5

• CA 19-9 tumor marker is elevated in up to 85% of cholangiocarcinoma patients and approximately 69% of pancreatic cancer patients, but it is not diagnostic and should not delay imaging. 1

• Endoscopic ultrasound with fine-needle aspiration provides tissue diagnosis and is particularly useful when imaging shows a pancreatic mass requiring histologic confirmation before treatment. 6

Critical Clinical Pitfalls

• Do not assume alcoholic hepatitis based on alcohol history alone—the cholestatic pattern and painless jaundice point to obstruction, not hepatocellular injury. 3

• Do not delay imaging waiting for tumor markers—CA 19-9 has low specificity and can be elevated in benign biliary obstruction. 1

• Recognize that normal transaminases do not exclude serious disease—cholangiocarcinoma and pancreatic cancer frequently present with isolated cholestatic enzyme elevation and normal or minimally elevated ALT/AST. 1, 2

• Ascites in the setting of obstructive jaundice signals advanced malignancy (peritoneal carcinomatosis or portal vein thrombosis) and dramatically worsens prognosis. 2